The Phase I trial — meaning it is the first in humans and had the goal of showing the therapy is safe — examined 12 patients with gastrointestinal cancers, including colon and rectal cancer.

Short-term results of VOLTAGE-A: Nivolumab monotherapy and subsequent radical surgery following preoperative chemoradiotherapy in patients with microsatellite stable and microsatellite ...

Many organizations help patients pay for cancer treatment, medication, and other expenses. Fred Hutch Cancer Center offers financial assistance to patients based on family need. Low-income patients ...